Vascular smooth muscle cells efficiently activate a new proteinase cascade involving plasminogen and fibronectin

Journal of Cellular Biochemistry

Volumn 88, Issue 6, 2003, Pages 1188-1201

  Houard, Xavier ^a   Monnot, Catherine ^a   Dive, Vincent ^b   Corvol, Pierre ^a   Pagano, Maurice ^a  

^a INSERM   (France)

^b DIF   (France)

Author keywords

Fibronectin; Fn proteinase; Plasminogen; Vascular smooth muscle cells

Indexed keywords

FIBRONECTIN; MATRIX METALLOPROTEINASE; PLASMIN; PLASMINOGEN; PROTEINASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HYDROLYSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DOMAIN; RAT; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, THORACIC; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; EXTRACELLULAR MATRIX PROTEINS; FIBRONECTINS; MATRIX METALLOPROTEINASES; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PLASMIN; PLASMINOGEN; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC; WOUND HEALING;

EID: 0037446064     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.10460     Document Type: Article

References (47)

1. Allaire E, Forough R, Clowes M, Starcher B, Clowes AW. 1998. Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model. J Clin Invest 102:1413-1420.
2. Baramova EN, Bajou K, Remacle A, L'Hoir C, Krell HW, Weidle UH, Noel A, Foidart JM. 1997. Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation. FEBS Lett 405:157-162.
3. Battle T, Arnal JF, Challah M, Michel JB. 1994. Selective isolation of rat aortic wall layers and their cell types in culture - Application to converting enzyme activity measurement. Tissue Cell 26:943-955.
4. Berman MB. 1993. Regulation of corneal fibroblast MMP-1 collagenase secretion by plasmin. Cornea 12:420-432.
5. Boudjennah L, Dalet-Fumeron V, Pagano M. 1998. Expression of collagenase/gelatinase activity from basement-membrane fibronectin - Isolation after limited proteolysis of a bovine lens capsule and molecular definition of this thiol-dependent zinc metalloproteinase. Eur J Biochem 255:246-254.
6. Carmeliet P, Collen D. 1998. Development and disease in proteinase-deficient mice: Role of the plasminogen, matrix metalloproteinase, and coagulation system. Thromb Res 91:255-285.
7. Carmeliet P, Moons L, Lijnen R, Baes M, Lemaitre V, Tipping P, Drew A, Eeckhout Y, Shapiro S, Lupu F, Collen D. 1997. Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet 17:439-444.
8. Chevalier X, Groult N, Emod I, Planchenault T. 1996. Proteoglycan-degrading activity associated with the 40 kDa collagen-binding fragment of fibronectin. Br J Rheumatol 35:506-514.
9. Clowes AW, Clowes MM, Au YP, Reidy MA, Belin D. 1990. Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res 67:61-67.
10. Ellis V, Whawell SA. 1997. Vascular smooth muscle cells potentiate plasmin generation by both urokinase and tissue plasminogen activator-dependent mechanisms: Evidence for a specific tissue-type plasminogen activator receptor on these cells. Blood 90:2312-2322.
11. Falcone DJ, Borth W, McCaffrey TA, Mathew J, McAdam K. 1994. Regulation of macrophage receptorbound plasmin by autoproteolysis. J Biol Chem 269: 32660-32666.
12. Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, Amento E, Libby P. 1994a. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res 75:181-189.
13. Galis ZS, Sukhova GK, Lark MW, Libby P. 1994b. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493-2503.
14. Gately S, Twardowski P, Stack MS, Cundiff DL, Grella D, Castellino FJ, Enghild J, Kwaan HC, Lee F, Kramer RA, Volpert O, Bouck N, Soff GA. 1997. The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin. Proc Natl Acad Sci USA 94:10868-10872.
15. George SJ, Baker AH, Angelini GD, Newby AC. 1998. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins. Gene Ther 5:1552-1560.
16. Gonzalez-Gronow M, Grenett HE, Weber MR, Gawdi G, Pizzo SV. 2001. Interaction of plasminogen with dipeptidyl peptidase IV initiates a signal transduction mechanism which regulates expression of matrix metalloproteinase-9 by prostate cancer cells. Biochem J 355: 397-407.
17. Grant MB, Caballero S, Bush DM, Spoerri PE. 1998. Fibronectin fragments modulate human retinal capillary cell proliferation and migration. Diabetes 47:1335-1340.
18. Hajjar KA, Harpel PC, Jaffe EA, Nachman RL. 1986. Binding of plasminogen to cultured human endothelial cells. J Biol Chem 261:11656-11662.
19. Hajjar KA, Gavish D, Breslow JL, Nachman RL. 1989. Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 339:303-305.
20. He CS, Wilhelm SM, Pentland AP, Marmer BL, Grant GA, Eisen AZ, Goldberg GI. 1989. Tissue cooperation in a proteolytic cascade activating human interstitial collagenase. Proc Natl Acad Sci USA 86:2632-2636.
21. Herbert JM, Carmeliet P. 1997. Involvement of u-PA in the anti-apoptotic activity of TGFbeta for vascular smooth muscle cells. FEBS Lett 413:401-404.
22. Herbert JM, Lamarche I, Carmeliet P. 1997. Urokinase and tissue-type plasminogen activator are required for the mitogenic and chemotactic effects of bovine fibroblast growth factor and platelet-derived growth factor-BB for vascular smooth muscle cells. J Biol Chem 272:23585-23591.
23. Homandberg GA, Meyers R, Xie DL. 1992. Fibronectin fragments cause chondrolysis of bovine articular cartilage slices in culture. J Biol Chem 267:3597-3604.
24. Kapila YL, Kapila S, Johnson PW. 1996. Fibronectin and fibronectin fragments modulate the expression of proteinases and proteinase inhibitors in human periodontal ligament cells. Matrix Biol 15:251-261.
25. Kassam G, Kwon M, Yoon CS, Graham KS, Young MK, Gluck S, Waisman DM. 2001. Purification and characterization of A61. Ah angiostatin-like plasminogen fragment produced by plasmin autodigestion in the absence of sulfhydryl donors. J Biol Chem 276:8924-8933.
26. Knight CG, Willenbrock F, Murphy G. 1992. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett 296:263-266.
27. Lambert Vidmar S, Lottspeich F, Emod I, Imhoff JM, KeilDlouha V. 1991. Collagen-binding domain of human plasma fibronectin contains a latent type-IV collagenase. Eur J Biochem 201:79-84.
28. Lee E, Vaughan DE, Parikh SH, Grodzinsky AJ, Libby P, Lark MW, Lee RT. 1996. Regulation of matrix metalloproteinases and plasminogen activator inhibitor-1 synthesis by plasminogen in cultured human vascular smooth muscle cells. Circ Res 78:44-49.
29. Lijnen HR, Ugwu F, Bini A, Collen D. 1998. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3). Biochemistry 37:4699-4702.
30. Lijnen HR, Arza B, Van Hoef B, Collen D, Declerck PJ. 2000. Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3). J Biol Chem 275:37645-37650.
31. Lottenberg R, Christensen U, Jackson CM, Coleman PL. 1981. Assay of coagulation proteases using peptide chromogenic and fluorogenic substrates. Methods Enzymol 80:341-361.
32. Mazzieri R, Masiero L, Zanetta L, Monea S, Onisto M, Garbisa S, Mignatti P. 1997. Control of type IV collagenase activity by components of the urokinaseplasmin system: A regulatory mechanism with cell-bound reactants. EMBO J 16:2319-32.
33. Meissauer A, Kramer MD, Schirrmacher V, Brunner G. 1992. Generation of cell surface-bound plasmin by cellassociated urokinase-type or secreted tissue-type plasminogen activator: A key event in melanoma cell invasiveness in vitro. Exp Cell Res 199:179-190.
34. Moore G, Liao S, Curci JA, Starcher BC, Martin RL, Hendricks RT, Chen JJ, Thompson RW. 1999. Suppression of experimental abdominal aortic aneurysms by systemic treatment with a hydroxamate-based matrix metalloproteinase inhibitor (RS 132908). J Vasc Surg 29: 522-532.
35. O'Reilly MS, Wiederschain D, Stetler-Stevenson WG, Folkman J, Moses MA. 1999. Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J Biol Chem 274:29568-29571.
36. Okada Y, Morodomi T, Enghild JJ, Suzuki K, Yasui A, Nakanishi I, Salvesen G, Nagase H. 1990. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur J Biochem 194:721-730.
37. Patterson BC, Sang QA. 1997. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem 272:28823-28825.
38. Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM, Thompson RW. 2000. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest 105:1641-1649.
39. Reidy MA, Irvin C, Lindner V. 1996. Migration of arterial wall cells. Expression of plasminogen activators and inhibitors in injured rat arteries. Circ Res 78:405-414.
40. Schedin PJ, Thackray LB, Malone P, Fontaine SC, Friis RR, Strange R. 1996. Programmed cell death and mammary neoplasia. Cancer Treat Res 83:3-22.
41. Schnepel J, Tschesche H. 2000. The proteloytic activity of the recombinant cryptic human fibronectin type IV collagenase from E. coli expression. J Protein Chem 19: 685-692.
42. Schor SL, Ellis I, Dolman C, Banyard J, Humphries MJ, Mosher DF, Grey AM, Mould AP, Sottile J, Schor AM. 1996. Substratum-dependent stimulation of fibroblast migration by the gelatin-binding domain of fibronectin. J Cell Sci 109:2581-2590.
43. Silverstein RL, Friedlander RJ, Jr, Nicholas RL, Nachman RL. 1988. Binding of Lys-plasminogen to monocytes/macrophages. J Clin Invest 82:1948-1955.
44. Stathakis P, Fitzgerald M, Matthias LJ, Chesterman CN, Hogg PJ. 1997. Generation of angiostatin by reduction and proteolysis of plasmin. Catalysis by a plasmin reductase secreted by cultured cells. J Biol Chem 272:20641-20645.
45. Thompson RW, Holmes DR, Mertens RA, Liao S, Botney MD, Mecham RP, Welgus HG, Parks WC. 1995. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest 96:318-326.
46. Wei L, Alhenc-Gelas F, Soubrier F, Michaud A, Corvol P, Clauser E. 1991. Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. J Biol Chem 266:5540-5546.
47. Xie DL, Meyers R, Homandberg GA. 1992. Fibronectin fragments in osteoarthritic synovial fluid. J Rheumatol 19:1448-1452.